TY - JOUR
T1 - Medical care of newborns born to mothers with confirmed or suspected severe acute respiratory syndrome coronavirus 2 infections in Japan
AU - the Committee of Neonatal Medicine in Japan Pediatric Society
AU - Morioka, Ichiro
AU - Toishi, Satoshi
AU - Kusaka, Takashi
AU - Wada, Kazuko
AU - Mizuno, Katsumi
AU - Arahori, Hitomi
AU - Onishi, Satoshi
AU - Kawai, Masahiko
AU - Shoji, Hiromichi
AU - Takahashi, Naoto
AU - Takayanagi, Toshimitsu
AU - Nagaya, Ken
AU - Hasegawa, Hisaya
AU - Hayakawa, Masahiro
AU - Hida, Mariko
AU - Fukuhara, Rie
AU - Matsumoto, Atsushi
AU - Miyazawa, Tokuo
AU - Yamada, Yasumasa
AU - Wada, Yuka
N1 - Funding Information:
This study was supported by grants from the Ministry of Health, Labor, and Welfare of Japan (R2‐Tokubetsu Kenkyu Jigyo) and the Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics (R2).
Funding Information:
This study was supported by grants from the Ministry of Health, Labor, and Welfare of Japan (R2-Tokubetsu Kenkyu Jigyo) and the Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics (R2). We thank all the chief pediatricians of the pediatric departments of the hospitals that participated in this survey. We also thank the following members of the Committee of Neonatal Medicine at the Japan Pediatric Society for their advice and suggestions for this survey: Drs Hitomi Arahori, Satoshi Onishi, Masahiko Kawai, Hiromichi Shoji, Naoto Takahashi, Toshimitsu Takayanagi, Ken Nagaya, Hisaya Hasegawa, Masahiro Hayakawa, Mariko Hida, Rie Fukuhara, Atsushi Matsumoto, Tokuo Miyazawa, Yasumasa Yamada, and Yuka Wada.
Publisher Copyright:
© 2021 Japan Pediatric Society.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Background: There are currently no definitive guidelines regarding newborns born to mothers with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to investigate the medical care and management that provided or would provide for such newborns. Methods: A web survey was conducted between September and October 2020. A total of 624 hospitals, which generally accept pregnant women for delivery, were involved in this study. The survey included the number of newborns born to mothers with confirmed SARS-CoV-2 infection and evaluated policies regarding the medical care and management of newborns born to mothers with confirmed or suspected SARS-CoV-2 infection. Results: Pregnant women with confirmed or suspected SARS-CoV-2 infection were accepted or planned to be accepted in 54% (334) of the hospitals. Out of 52 newborns born to mothers with confirmed SARS-CoV-2 infection, SARS-CoV-2 RNA was detected from the nasopharyngeal swab of one newborn shortly after birth. The types of personal protective equipment during the delivery, the separation of the newborns from the mothers, the SARS-CoV-2 testing methods, and the use of incubators during the quarantine period were uniformly provided. However, the methods of ventilator treatment in the event of respiratory disorders, feeding during maternal isolation, and de-quarantine and discharge criteria varied. Conclusions: This survey demonstrated that one newborn detected a SARS-CoV-2 RNA shortly after birth out of 52 newborns who were born to mothers with confirmed SARS-CoV-2 infection. The policies regarding medical care and management for these newborns in Japan were provided.
AB - Background: There are currently no definitive guidelines regarding newborns born to mothers with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to investigate the medical care and management that provided or would provide for such newborns. Methods: A web survey was conducted between September and October 2020. A total of 624 hospitals, which generally accept pregnant women for delivery, were involved in this study. The survey included the number of newborns born to mothers with confirmed SARS-CoV-2 infection and evaluated policies regarding the medical care and management of newborns born to mothers with confirmed or suspected SARS-CoV-2 infection. Results: Pregnant women with confirmed or suspected SARS-CoV-2 infection were accepted or planned to be accepted in 54% (334) of the hospitals. Out of 52 newborns born to mothers with confirmed SARS-CoV-2 infection, SARS-CoV-2 RNA was detected from the nasopharyngeal swab of one newborn shortly after birth. The types of personal protective equipment during the delivery, the separation of the newborns from the mothers, the SARS-CoV-2 testing methods, and the use of incubators during the quarantine period were uniformly provided. However, the methods of ventilator treatment in the event of respiratory disorders, feeding during maternal isolation, and de-quarantine and discharge criteria varied. Conclusions: This survey demonstrated that one newborn detected a SARS-CoV-2 RNA shortly after birth out of 52 newborns who were born to mothers with confirmed SARS-CoV-2 infection. The policies regarding medical care and management for these newborns in Japan were provided.
KW - breast milk
KW - coronavirus disease 2019
KW - infection
KW - newborn
KW - pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85118951930&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118951930&partnerID=8YFLogxK
U2 - 10.1111/ped.14855
DO - 10.1111/ped.14855
M3 - Article
C2 - 34041810
AN - SCOPUS:85118951930
SN - 1328-8067
VL - 64
JO - Pediatrics International
JF - Pediatrics International
IS - 1
M1 - e14855
ER -